SERIES A-1 CONVERTIBLE PREFERRED STOCK ISSUANCE AGREEMENTStockholders’ Agreement • November 7th, 2011 • Radius Health, Inc. • Blank checks • Delaware
Contract Type FiledNovember 7th, 2011 Company Industry JurisdictionTHIS SERIES A-1 CONVERTIBLE PREFERRED STOCK ISSUANCE AGREEMENT, dated this 11th day of May, 2011 (“Agreement”) is entered into by and among Radius Health, Inc., a Delaware corporation (the “Corporation”), and Ipsen Pharma SAS, a French corporation formerly known as SCRAS S.A.S. (“Investor”).
LICENSE AGREEMENT AMENDMENT NO. 2Stockholders’ Agreement • November 7th, 2011 • Radius Health, Inc. • Blank checks • Delaware
Contract Type FiledNovember 7th, 2011 Company Industry JurisdictionRadius Health Inc., a Delaware Corporation, formerly known as Nuvios, Inc. (“Radius”), and Ipsen Pharma SAS, a French corporation formerly known as SCRAS S.A.S., on behalf of itself and its Affiliates (Ipsen) (the “Parties”) entered into the certain License Agreement as of September 27, 2005 (“Effective Date”), as amended by that certain License Agreement Amendment No. effective as of September 12, 2007 (as amended, the “Agreement”). The Parties wish to enter into this License Agreement Amendment No. 2 (“Amendment No. 2”) effective as of , 2011 (“Amendment Date”) to amend certain provisions of the Agreement.